An in vitro study reveals the nutraceutical potential of punicic acid relevant to diabetes via enhanced GLUT4 expression and adiponectin secretion

Food and Function

Volumn 5, Issue 10, 2014, Pages 2590-2601

  Anusree, S S ^a   Priyanka, A ^a   Nisha, V M ^a   Das, Arya A ^b   Raghu, K G ^a  

^a REGIONAL RESEARCH LABORATORY CSIR   (India)

^b CSIR NIIST   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLOGY; ENERGY TRANSFER; FORSTER RESONANCE ENERGY TRANSFER; LIGANDS; PLANTS (BOTANY);

BINDING AFFINITIES; BIOLOGICAL CHARACTERIZATION; GLUCOSE UPTAKE ACTIVITIES; LIGAND BINDING DOMAIN; METABOLIC SYNDROMES; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; THERAPEUTIC AGENTS; TIME-RESOLVED FLUORESCENCE;

BINDING ENERGY;

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPONECTIN; ANTIDIABETIC AGENT; GLUCOSE TRANSPORTER 4; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; LINOLENIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PUNICIC ACID; ROSIGLITAZONE; SLC2A4 PROTEIN, MOUSE; TRIACYLGLYCEROL;

3T3 CELL LINE; ADIPOCYTE; ANIMAL; CELL DIFFERENTIATION; CHEMISTRY; DIABETES MELLITUS, TYPE 2; DIET SUPPLEMENTATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; LYTHRACEAE; METABOLISM; MOUSE; PLANT SEED; SECRETION (PROCESS);

3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ANIMALS; CELL DIFFERENTIATION; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORTER TYPE 4; GLYCEROLPHOSPHATE DEHYDROGENASE; HYPOGLYCEMIC AGENTS; LINOLENIC ACIDS; MICE; PPAR GAMMA; PUNICACEAE; SEEDS; THIAZOLIDINEDIONES; TRIGLYCERIDES;

EID: 84907543773     PISSN: 20426496     EISSN: 2042650X     Source Type: Journal    
DOI: 10.1039/c4fo00302k     Document Type: Article

References (45)

1. R. H. Eckel S. M. Grundy P. Z. Zimmet The metabolic syndrome Lancet 2005 365 1415-1428.
2. P. W. F. Wilson R. B. D'Agostino H. Parise L. Sullivan L. B. Meigs Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus Circulation 2005 112 3066-3072.
3. R. D. Grave S. Calugi E. Centis R. Marzocchi M. El Ghoch G. Marchesini Lifestyle modification in the management of the metabolic syndrome: achievements and challenges Diabetes, Metab. Syndr. Obes.: Targets Ther. 2010 3 373-385.
4. B. Salim Diabetes mellitus and its treatment Int. J. Diabetes Metab. 2005 13 111-134.
5. G. Davi F. Santilli C. Patrono Nutraceuticals in diabetes and metabolic syndrome Cardiovasc. Ther. 2010 28 216-226.
6. C. S. Ramaa A. R. Shirode A. S. Mundada V. J. Kadam Nutraceuticals – an emerging era in the treatment and prevention of cardiovascular diseases Curr. Pharm. Biotechnol. 2006 7 15-23.
7. M. Viladomiu R. Hontecillas P. Lu J. Bassaganya-Riera Preventive and prophylactic mechanisms of action of pomegranate bioactive constituents J. Evidence-Based Complementary Altern. Med. 2013 2013 789764.
8. J. Bassaganya-Riera J. Skoneczka D. G. J. Kingston A. Krishnan S. A. Misyak A. J. Guri A. Pereira A. B. Carter P. Minorsky R. Tumarkin R. Hontecillas Mechanisms of action and medicinal applications of abscisic acid Curr. Med. Chem. 2010 17 467-478.
9. S. I. Rizvi N. Mishra Traditional Indian medicines used for the management of diabetes mellitus J. Diabetes Res. 2013 2013 712092.
10. M. P. Riya K. A. Antu S. Pal A. K. Srivastava S. Sharma K. G. Raghu Nutraceutical potential of Aerva lanata (L.) Juss. Ex Schult ameliorates secondary complications in streptozotocin-induced diabetic rats Food Funct. 2014 10.1039/c4fo00013g.
11. D. K. Patel S. K. Prasad R. Kumar S. Hemalatha An overview on antidiabetic medicinal plants having insulin mimetic property Asian Pac. J. Trop. Biomed. 2012 2 320-330.
12. R. M. Srinivasa Medicinal plants with potent antidiabetic properties J. Sci. Food Agric. 2007 87 743-750.
13. S. A. Kalekar R. P. Munshi S. S. Bhalerao U. M. Thatte Insulin sensitizing effect of 3 Indian medicinal plants: an in vitro study Indian J. Pharmacol. 2013 45 30-33.
14. T. M. Larsen S. Toubro A. Astrup PPAR gamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? Int. J. Obes. 2003 27 147-161.
15. K. Schoonjans B. Staels J. Auwerx The peroxisome proliferator activated receptors (PPARs) and their effect on lipid metabolism and adipocyte differentiation Biochim. Biophys. Acta 1996 1302 93-109.
16. N. Cho Y. Momose Peroxisome proliferator activated receptor gamma agonists as insulin sensitizers: from the discovery to recent progress Curr. Top. Med. Chem. 2008 8 1483-1507.
17. M. Ahmadian J. M. Suh N. Hah C. Liddle A. R. Atkins M. Downes R. M. Evans PPARγ signalling and metabolism: the good, the bad and the future Nat. Med. 2013 99 557-566.
18. A. Rubenstrunk R. Hanf D. W. Hum J. C. Fruchart B. Staels Safety issues and prospects for future generations of PPAR modulators Biochim. Biophys. Acta 2007 1771 1065-1081.
19. M. Penumetcha N. Santanam Nutraceuticals as ligands of PPARγ PPAR Res. 2012 2012 858352.
20. J. Bassaganya-Riera A. J. Guri R. Hontecillas Treatment of obesity-related complications with novel classes of naturally occurring PPAR agonists J. Obes. 2011 2011 897894.
21. R. Hontecillas M. O'Shea A. Einerhand M. Diguardo J. Bassaganya-Riera Activation of PPAR α and γ by punicic acid ameliorates glucose tolerence and suppresses obesity related inflammation J. Am. Coll. Nutr. 2009 28 184-195.
22. A. J. Gilde J. C. Fruchart B. Staels Peroxisome Proliferator-Activated Receptors at the Crossroads of Obesity, Diabetes, and Cardiovascular Disease J. Am. Coll. Cardiol. 2006 48 24-32.
23. N. K. Salam T. H. W. Huang B. P. Kotta M. S. Kim Y. Li D. E. Hibbs Novel PPAR gamma agonists identified from a natural products library; a virtual screening, induced fit docking and biological assay study Chem. Biol. Drug Des. 2008 71 57-70.
24. O. Rau M. Wurglics T. Dingermann M. Abdel-Tawab M. Schubert-Zsilavecz Screening of herbal extracts for activation of the human peroxisome proliferator activated receptor Pharmazie 2006 61 952-956.
25. Z. Liao Z. Wu M. Wu Cirsium japonicum flavones enhance adipocyte differentiation and glucose uptake in 3T3-L1 cells Biol. Pharm. Bull. 2012 35 855-860.
26. S. S. Choi B. Y. Cha Y. S. Lee T. Yonezawa T. Teruya K. Nagai J. T. Woo Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells Life Sci. 2009 84 908-914.
27. Y. Shimojo K. Kosaka T. Shirasawa Effect of Ganoderma lucidum extract on adipocyte differentiation and adiponectin gene expression in the murine preadipocytes Cell Line, 3T3-L1 Phytother. Res. 2011 25 202-207.
28. L. Guasch E. Sala M. Mulero C. Valls M. J. Salvadó G. Pujadas S. Garcia-Vallvé Identification of PPAR gamma partial agonists of natural (II): in silico prediction in natural extracts with known antidiabetic activity PLoS One 2013 8 e55889.
29. F. Gregoire C. M. Smas H. S. Sul Understanding adipocyte differentiation Physiol. Rev. 1998 78 784-809.
30. L. H. Wise H. Green Participation of one isozyme of cytosolic glycerophosphate dehydrogenase in the adipose conversion of 3T3 Cells J. Biol. Chem. 1979 254 273-275.
31. M. P. Riya K. A. Antu T. Vinu K. C. Chandrakanth K. S. Anilkumar K. G. Raghu An in vitro study reveals nutraceutical properties of Ananas comosus (L.) Merr. Var. Mauritius fruit residue beneficial to diabetes J. Sci. Food Agric. 2013 94 943-950.
32. J. Naowaboot C. H. Chung P. Pannangpetch R. Choi B. H. Kim M. Y. Lee U. Kukongviriyapan Mulberry leaf extract increases adiponectin in murine 3T3-L1 adipocytes Nutr. Res. 2012 32 39-44.
33. Y. Fu N. Luo R. L. Klein W. T. Garvey Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation J. Lipid Res. 2005 46 1369-1379.
34. G. M. Morris R. Huey W. Lindstrom M. F. Sanner R. K. Belew D. S. Goodsell A. J. Olson AutoDock4 and Autodock Tools 4: Automated docking with selective receptor flexibility J. Comput. Chem. 2009 30 2785-2791.
35. N. Mahindroo C. C. Wang C. C. Liao C. F. Huang I. L. Lu T. W. Lien Y. H. Peng W. J. Huang Y. T. Lin M. C. Hsu C. H. Lin C. H. Tsai J. T. A. Hsu X. Chen P. C. Lyu Y. S. Chao S. Y. Wu H. P. Hseih Indol-1-yl acetic acids as peroxisome proliferator activated receptor agonists: design, synthesis, structural biology, and molecular docking studies J. Med. Chem. 2006 49 1212-1216.
36. K. C. Hsu Y. F. Chen S. R. Lin J. M. Yang iGEMDOCK: a graphical environment of enhancing iGEMDOCK using pharmacological interactions and post-screening analysis BMC Bioinf. 2011 12 S1 S33.
37. S. W. Chung B. Y. Kang S. H. Kim Y. K. Pak D. Cho G. Trinchieri T. S. Kim Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide activated mouse macrophages via direct ineraction between peroxisome proliferator-activated receptor-γ and nuclear factor-kB J. Biol. Chem. 2000 275 32681-32687.
38. 12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2 arachidonyl glycerol, activates peroxisome proliferator activated receptor γ Mol. Pharmacol. 2011 80 201-209.
39. S. N. Lewis L. Brannan A. J. Guri P. Lu R. Hontecillas J. Bassaganya-Riera D. R. Bevan Dietary α eleostearic acid ameliorates experimental inflammatory bowel disease in mice by activating peroxisome proliferator-activated receptor γ PLoS One 2011 6 e24031.
40. Y. Yang W. Shang L. Zhou B. Jiang H. Jin M. Chen Emodin with PPARγ ligand-binding activity promotes adipocyte differentiation and increases glucose uptake in 3T3-Ll cells Biochem. Biophys. Res. Commun. 2007 353 225-230.
41. C. Kühn N. E. Arapogianni M. Halabalaki J. Hempel N. Hunger J. Wober A. L. Skaltsounis G. Vollmer Constituents from Cistus salvifolius (Cistaceae) activate peroxisome proliferator activated receptor γ but not δ and stimulate glucose uptake by adipocytes Planta Med. 2011 77 346-353.
42. A. Leonardini L. Laviola S. Perrini A. Natalicchio F. Giorgino Cross-talk between PPARγ and insulin signaling and modulation of insulin sensitivity PPAR Res. 2009 2009 818945.
43. M. Lehrke M. A. Lazar The many faces of PPARγ Cell 2005 123 993-999.
44. J. W. Baynes S. R. Thorpe Role of oxidative stress in diabetic complications Diabetes 1999 48 1-9.
45. J. Yan Y. Zhao S. Suo Y. Liu B. Zhao Green tea catechins ameliorate adipose insulin resistance by improving oxidative stress Free Radical Biol. Med. 2012 52 1648-1657.